ranimustine has been researched along with Thrombocythemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajiro, Y; Honda, H; Ito, J; Iyoda, M; Kitazawa, K; Kuroki, A; Nagai, H; Shibata, T; Sugisaki, T; Uchida, J | 1 |
| Kikuchi, H; Nagano, T; Nasu, M; Ohtsuka, E; Saburi, Y; Satoh, J; Taniguchi, K; Tezono, K | 1 |
| Hirata, M; Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Shibata, H; Taniguchi, N; Tsubaki, K | 1 |
3 other study(ies) available for ranimustine and Thrombocythemia
| Article | Year |
|---|---|
[Focal segmental glomerulosclerosis in a patient with polycythemia vera].
Topics: Aged; Disease Progression; Female; Glomerulosclerosis, Focal Segmental; Humans; Hydroxyurea; Nitrosourea Compounds; Phlebotomy; Polycythemia Vera; Proteinuria; Renal Dialysis; Thrombocytosis | 2005 |
[Essential thrombocythemia transformed to minimally differentiated acute myeloid leukemia].
Topics: Cell Transformation, Neoplastic; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Nitrosourea Compounds; Thrombocytosis | 1995 |
[Phase II study on oral administration of MCNU (ranomustine) tablet. Hanshin Cooperative Study Group on Hematological Disorders].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Leukemia, Myeloid; Male; Middle Aged; Nitrosourea Compounds; Polycythemia; Tablets; Thrombocytosis | 1986 |